Search

Search Constraints

You searched for: Author/Creator Samineni, Divya

Search Results

1. A Phase I dose‐escalation study of DCLL9718S, an antibody‐drug conjugate targeting C‐type lectin‐like molecule‐1 (CLL‐1) in patients with acute myeloid leukemia. Issue 5 (11th March 2021)

2. A randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthma. Issue 1 (December 2016)

3. Clinical pharmacology of vc-MMAE antibody–drug conjugates in cancer patients: learning from eight first-in-human Phase 1 studies. Issue 1 (1st January 2020)

4. Impact of Physiologically Based Pharmacokinetics, Population Pharmacokinetics and Pharmacokinetics/Pharmacodynamics in the Development of Antibody‐Drug Conjugates. (17th November 2020)

5. Impact of Physiologically Based Pharmacokinetics, Population Pharmacokinetics and Pharmacokinetics/Pharmacodynamics in the Development of Antibody‐Drug Conjugates. (17th November 2020)

8. Physiologically Based Pharmacokinetic Model‐Informed Drug Development for Polatuzumab Vedotin: Label for Drug‐Drug Interactions Without Dedicated Clinical Trials. (17th November 2020)

9. Prediction of Human Pharmacokinetics of Antibody–Drug Conjugates From Nonclinical Data. Issue 5 (11th June 2019)

10. Time‐to‐Event Modeling of Peripheral Neuropathy: Platform Analysis of Eight Valine‐Citrulline‐Monomethylauristatin E Antibody–Drug Conjugates. (10th July 2019)